Autophagy in vascular dementia and natural products with autophagy regulating activity

Pharmacol Res. 2021 Aug:170:105756. doi: 10.1016/j.phrs.2021.105756. Epub 2021 Jul 5.

Abstract

Chronic Cerebral Hypoperfusion(CCH)-induced vascular dementia(VD) is a common neurodegenerative disease which seriously affects the patient's quality of life. Therefore, it is critical to find an effective treatment of VD. Autophagy is a natural regulated mechanism that can remove dysfunctional proteins and organelles, however, over-activation or under-activation can of autophagy can induce the apoptosis of cells. Although autophagy plays a role in the central nervous system is unquestionable, the effects of autophagy in the ischemic brain are still controversial. Some autophagy regulators have been tested, suggesting that both activation and inhibition of autophagy can improve the cognitive function. This article reviews the role of autophagy in CCH-induced VD to discuss whether autophagy has the potential to become a target for drug development and provides several potential compounds for treating vascular dementia.

Keywords: Autophagy; Chronic cerebral hypoperfusion; Natural products; Vascular dementia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins / metabolism
  • Autophagy / drug effects*
  • Autophagy-Related Proteins / metabolism
  • Biological Products / adverse effects
  • Biological Products / therapeutic use*
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Cerebrovascular Circulation
  • Dementia, Vascular / drug therapy*
  • Dementia, Vascular / metabolism
  • Dementia, Vascular / pathology
  • Dementia, Vascular / physiopathology
  • Humans
  • Signal Transduction

Substances

  • Apoptosis Regulatory Proteins
  • Autophagy-Related Proteins
  • Biological Products